Xphyto Therapeutics (XPHY.C) diagnostic partner, 3a-Diagnostics GmbH, is getting onboard with the latest rush to develop a COVID-19 diagnostic kit, using reverse transcription polymerase chain reaction (RT-PCR) technology, which brings anticipated results in 25 minutes, according to a press release.

The test is planned for commercial launch as a CE-IVD-certified (in vitro diagnostic) product in the European Union by Q1, 2021.

“Applying 3a’s proprietary enhanced RNA technology to PCR testing was a logical next step in our product development pipeline. We are currently developing two saliva-based tests to detect SARS-CoV-2 RNA. The RT-PCR test system is to be employed in a laboratory setting using minimal equipment with sample to results in less than 25 minutes. The rapid test system is a low-cost, self-administered, disposable test with sample to results in less than 15 minutes. Both systems are on track for European commercialization in Q1 2021,” said Dr. Heinrich Jehle, managing director of 3a-Diagnostics.

The final validation studies for both RNA test systems are going to take place in Germany in Q4, 2020. 3a will continue with its industrial design, product usability, labelling compliance, regulatory approval and production planning work as its doing its validation studies.

Xphyto announced an agreement signed with 3a Diagnostics on April 20, 2020, that deal with a technology purchase and licensing agreement to develop and commercialize a real-time, inexpensive, user-friendly screening test using their 3a’s pathogen-specific biosensor and Xphyto’s oral dissolvable drug delivery system.

In July, 2020, they tacked on an addition to the agreement that includes 3a’s RNA system and related intellectual property into the agreement, and also includes exclusive commercial rights for the rapid test and RT-PCR test.

—Joseph Morton

Written By:

Joseph Morton

Joseph is a Vancouver-based author and journalist with both a communications degree and journalism diploma (and a few novels) under his belt. His joie de vivre is to spin difficult technical topics into more human-centric narratives. Buy him a coffee and he'll talk your ear off for hours about privacy issues, blockchain, cryptocurrency and martial arts. Don't talk to him if you're either a tomato, a bully, or if you're not a fan of either 1984 or Tender is the Night. No. You can still talk to him. Just be prepared to be told why you're wrong.

More By This Author
Tags:
Biotech
3a Diagnostics
Canadian Biotech
COVID-19 detection
COVID-19 test kits
drug delivery system
European Union
everse transcription polymerase chain reaction
rt-pcr
XPHY.C
Xphyto
Xphyto Therapeutics
0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x